HER2 dendritic cell vaccines
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-02-01 / Clin Breast Cancer 2003 Feb;3 Suppl 4:S164-72Dendritic cell therapy of cancer: can it fulfill its promise?
/in Dendritic Cells, International Publications /von 2003-02-01 / Expert Rev Anticancer Ther 2003 Feb;3(1):1-3Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease
/in International Publications, Malignant Melanoma /von 2003-02-01 / J Dtsch Dermatol Ges 2003 Feb;1(2):120-5Fusions of breast cancer and dendritic cells as a novel cancer vaccine
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-02-01 / Clin. Breast Cancer 2003 Feb;3 Suppl 4:S158-63Dendritic cell vaccination and viral infection–animal models
/in Chronic Virus Hepatitis, International Publications /von 2003-01-01 / Curr. Top. Microbiol. Immunol. 2003;276:199-214The first 1000 dendritic cell vaccinees
/in Dendritic Cells, International Publications /von 2003-01-01 / Cancer Invest. 2003;21(6):873-86Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine
/in HIV/AIDS, International Publications /von 2003-01-01 / Nat. Med. 2003 Jan;9(1):13-4Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-83Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer
/in Breast Cancer, International Publications /von 2003-01-01 / Clin. Cancer Res. 2003 Jan;9(1):285-94IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de